Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP685528.RAKOHANULpVLqw0P8RDZznfGzUYu7vd7CKldTmMbnFENY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP685528.RAKOHANULpVLqw0P8RDZznfGzUYu7vd7CKldTmMbnFENY130_assertion type Assertion NP685528.RAKOHANULpVLqw0P8RDZznfGzUYu7vd7CKldTmMbnFENY130_head.
- NP685528.RAKOHANULpVLqw0P8RDZznfGzUYu7vd7CKldTmMbnFENY130_assertion description "[In small cell lung cancer (SCLC), non-small cell lung cancer (NSCLC), and malignant pleural mesothelioma (MPM), MET is dysregulated via overexpression, constitutive activation, gene amplification, ligand-dependent activation, mutation or epigenetic mechanisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP685528.RAKOHANULpVLqw0P8RDZznfGzUYu7vd7CKldTmMbnFENY130_provenance.
- NP685528.RAKOHANULpVLqw0P8RDZznfGzUYu7vd7CKldTmMbnFENY130_assertion evidence source_evidence_literature NP685528.RAKOHANULpVLqw0P8RDZznfGzUYu7vd7CKldTmMbnFENY130_provenance.
- NP685528.RAKOHANULpVLqw0P8RDZznfGzUYu7vd7CKldTmMbnFENY130_assertion SIO_000772 18672314 NP685528.RAKOHANULpVLqw0P8RDZznfGzUYu7vd7CKldTmMbnFENY130_provenance.
- NP685528.RAKOHANULpVLqw0P8RDZznfGzUYu7vd7CKldTmMbnFENY130_assertion wasDerivedFrom befree-2016 NP685528.RAKOHANULpVLqw0P8RDZznfGzUYu7vd7CKldTmMbnFENY130_provenance.
- NP685528.RAKOHANULpVLqw0P8RDZznfGzUYu7vd7CKldTmMbnFENY130_assertion wasGeneratedBy ECO_0000203 NP685528.RAKOHANULpVLqw0P8RDZznfGzUYu7vd7CKldTmMbnFENY130_provenance.